InspireMD initiates voluntary US recall of CGuard Prime 135cm carotid stent delivery system
InspireMD recently shared that, in consultation with the US Food and Drug Administration (FDA), the company has initiated a voluntary recall in the USA...
US FDA approves InspireMD’s IDE application for CGUARDIANS III pivotal study
InspireMD recently announced that the US Food and Drug Administration (FDA) has approved the company’s investigational device exemption (IDE) application to initiate the CGUARDIANS...
Nectero EAST system demonstrates “profound” impact on reducing AAA growth at two years in...
Nectero Therapeutics recently released two-year outcomes data from the company’s first-in-human (FIH) trial of their investigational Nectero Endovascular Aneurysm Stabilisation Treatment (EAST) system. The...
Do women with small AAA need early EVAR? WARRIORS trial investigates
“Women with aortic aneurysms are more likely to die than men with aortic aneurysms.” This was the salient opening line of Colin Bicknell’s (Imperial...
